Detalhe da pesquisa
1.
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.
Anticancer Drugs
; 28(7): 787-794, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28562379